{"url_path":"/sec/clnn/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1822791/0001437749-26-016878-index.html","accession_number":"0001437749-26-016878","cik":"0001822791","ticker":"CLNN","issuer_name":"Clene Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1822791/0001437749-26-016878-index.html","primary_entity_key":"0001822791","primary_entity_name":"Clene Inc."},"word_count":637,"has_tables":true,"body_markdown":"**Item 6. Exhibits**\n\n \n\n**Exhibit Number**\n\n \n\n**Exhibit Description**\n\n1.1\n \n[Underwriting Agreement, dated May 5, 2026, by and between Clene Inc. and Canaccord Genuity LLC (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed by the registrant on May 5, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926014946/ex_948954.htm)\n\n3.1\n\n \n\n[Fourth Amended and Restated Certificate of Incorporation of Clene Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the registrant on May 11, 2023).](http://www.sec.gov/Archives/edgar/data/1822791/000143774923013721/ex_517370.htm)\n\n3.2\n \n[Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Clene Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the registrant on May 30, 2024).](http://www.sec.gov/Archives/edgar/data/0001822791/000143774924018759/ex_680309.htm)\n\n3.3\n \n[Certificate of Amendment to the Fourth Amended and Restated Certificate of Incorporation of Clene Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed by the registrant on July 9, 2024).](http://www.sec.gov/Archives/edgar/data/1822791/000143774924022352/ex_692896.htm)\n\n3.4\n\n \n\n[Bylaws of Clene Inc. (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed by the Registrant on January 5, 2021).](http://www.sec.gov/Archives/edgar/data/1822791/000121390021000487/ea132520ex3-2_cleneinc.htm)\n\n4.1\n \n[Form of Series A Warrant (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed by the Registrant on January 13, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/ex_905533.htm)\n\n4.2\n \n[Form of Series B Warrant (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed by the Registrant on January 13, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/ex_905534.htm)\n\n10.1\n \n[Securities Purchase Agreement, dated January 8, 2026, by and between Clene Inc. and the Purchasers signatory thereto (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Registrant on January 13, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/ex_905535.htm)\n\n10.2\n \n[Placement Agency Agreement, dated January 8, 2026, by and between Clene Inc. and BTIG, LLC (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed by the Registrant on January 13, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926001196/ex_905536.htm)\n\n10.3#\n \n[Subaward Agreement, dated March 13, 2026, by and between Clene Nanomedicine, Inc. and New York University (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed by the Registration on March 17, 2026).](http://www.sec.gov/Archives/edgar/data/1822791/000143774926008482/ex_933257.htm)\n\n10.4*\n \n[Letter Agreement, dated April 22, 2026, by and between Clene Inc. and 4Life Research, LLC.](ex_954541.htm)\n\n10.5*\n \n[Form of Second Amended & Restated Senior Secured Convertible Promissory Note.](ex_961349.htm)\n\n31.1*\n\n \n\n[Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.](ex_908787.htm)\n\n31.2*\n\n \n\n[Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities and Exchange Act of 1934, as amended.](ex_908788.htm)\n\n32.1**\n\n \n\n[Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex_908789.htm)\n\n32.2**\n\n \n\n[Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex_908790.htm)\n\n101.INS\n\n \n\nInline XBRL Instance Document.\n\n101.SCH\n\n \n\nInline XBRL Taxonomy Extension Schema Document.\n\n101.CAL\n\n \n\nInline XBRL Taxonomy Extension Calculation Linkbase Document.\n\n101.DEF\n\n \n\nInline XBRL Taxonomy Extension Definition Linkbase Document.\n\n101.LAB\n\n \n\nInline XBRL Taxonomy Extension Label Linkbase Document.\n\n101.PRE\n\n \n\nInline XBRL Taxonomy Extension Presentation Linkbase Document.\n\n104\n\n \n\nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).\n\n \n\n*\n\nFiled herewith.\n\n \n\n**\n\nFurnished herewith.\n\n \n#\n\nSchedules and similar attachments to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. We agree to furnish supplementally a copy of such omitted materials to the SEC upon request.\n\n \n\n43\n\n[Table of Contents](#toc)\n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\n \n\n \n\n**CLENE INC.**\n\n \n \n \n\nDated: May 14, 2026\n\nBy:\n\n/s/ Robert Etherington\n\n \n\nName:\n\nRobert Etherington\n\n \n\nTitle:\n\nPresident, Chief Executive Officer and Director\n\n \n \n\nDated: May 14, 2026\n\nBy:\n\n/s/ Morgan R. Brown\n\n \n\nName:\n\nMorgan R. Brown\n\n \n\nTitle:\n\nChief Financial Officer\n\n \n\n44"}